View Clinical Trial (Medical Research Study)

A Long Term Safety Study of MK4305 in Patients With Primary Insomnia - NCT01021813-40217(Clinical Trial 446156)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Louisville
State:  
KY
Zip Code: 40217
Conditions: Insomnia
Purpose: This study will establish the safety and tolerability of MK4305 when administered for up to 14 months.
Study summary:
Criteria: Inclusion Criteria: - Patient has a diagnosis of primary insomnia - Patient is able to read, understand, and complete questionnaires and diaries Exclusion Criteria: - If female, patient is pregnant - Patient expects to donate eggs or sperm during the study - Patient has any history of a neurological disorder - Patient has a history of clinically unstable cardiovascular disorder within the last 6 months - Patient has a history of bipolar disorder - Patient has a psychiatric condition that requires treatment with a medication prohibited by the study, or any other psychiatric condition that would interfere with the patient's ability to participate in the study - Patient has a history of substance abuse/dependence - Patient has a history of cancer - Patient has a history of uncontrolled diabetes - Patient has travelled across > 3 time zones or > 3 hour time difference in the last 2 weeks - Patient has a history of permanent night shift work or rotating day/night shift work in the past 2 weeks
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: April 13, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.